IRIS
FURFARO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.401
NA - Nord America 4.283
AS - Asia 3.833
SA - Sud America 796
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 120
OC - Oceania 15
Totale 13.694
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.929
RU - Federazione Russa 2.272
SG - Singapore 1.276
IT - Italia 1.114
CN - Cina 980
BR - Brasile 635
HK - Hong Kong 554
VN - Vietnam 360
BD - Bangladesh 261
FR - Francia 216
CA - Canada 171
DE - Germania 154
GB - Regno Unito 139
SE - Svezia 126
NL - Olanda 94
IN - India 75
FI - Finlandia 67
MX - Messico 56
AR - Argentina 55
JP - Giappone 50
PL - Polonia 49
IQ - Iraq 46
TR - Turchia 38
ID - Indonesia 37
ZA - Sudafrica 36
ES - Italia 35
AT - Austria 32
EG - Egitto 32
EC - Ecuador 30
CO - Colombia 28
JM - Giamaica 21
CR - Costa Rica 20
MY - Malesia 18
UA - Ucraina 17
NP - Nepal 15
PK - Pakistan 15
AU - Australia 14
CL - Cile 13
PT - Portogallo 13
TT - Trinidad e Tobago 13
GT - Guatemala 12
HN - Honduras 12
NI - Nicaragua 12
PY - Paraguay 12
SA - Arabia Saudita 12
JO - Giordania 11
MA - Marocco 11
SV - El Salvador 10
UZ - Uzbekistan 10
VE - Venezuela 10
IE - Irlanda 9
TN - Tunisia 9
BE - Belgio 8
LU - Lussemburgo 8
AE - Emirati Arabi Uniti 7
PH - Filippine 7
SY - Repubblica araba siriana 7
TW - Taiwan 7
CW - ???statistics.table.value.countryCode.CW??? 6
IL - Israele 6
IR - Iran 6
OM - Oman 6
PE - Perù 6
RO - Romania 6
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
GP - Guadalupe 5
GR - Grecia 5
LT - Lituania 5
LY - Libia 5
CH - Svizzera 4
ET - Etiopia 4
KE - Kenya 4
KY - Cayman, isole 4
LB - Libano 4
PR - Porto Rico 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EE - Estonia 3
KW - Kuwait 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
BZ - Belize 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
KR - Corea 2
LC - Santa Lucia 2
MD - Moldavia 2
MK - Macedonia 2
PA - Panama 2
SI - Slovenia 2
TG - Togo 2
Totale 13.432
Salva come PNG Salva come JPEG
Città #
Singapore 643
Ashburn 604
San Jose 600
Hong Kong 539
Moscow 478
Dallas 297
Milan 237
Council Bluffs 229
Beijing 186
Hefei 179
New York 175
Phoenix 160
Lauterbourg 155
Ho Chi Minh City 145
Los Angeles 117
Santa Clara 109
Hanoi 72
Shanghai 70
Munich 67
Princeton 62
Rome 61
Lawrence 59
São Paulo 56
Montreal 43
Orem 42
Chicago 38
Helsinki 38
Warsaw 37
Naples 34
Toronto 30
Denver 29
Frankfurt am Main 29
Miano 29
Brooklyn 27
Tokyo 26
Manchester 25
Buffalo 24
Johannesburg 24
London 24
North Bergen 24
Mexico City 23
Poplar 23
Chennai 22
Atlanta 21
Stockholm 21
Bologna 19
Florence 19
Da Nang 18
Seattle 18
Bari 17
Boston 17
Charlotte 17
Nuremberg 17
Baghdad 16
Ankara 15
Basra 15
Curitiba 15
Rio de Janeiro 15
Vienna 15
Mumbai 14
Houston 13
Kingston 13
Turin 13
Turku 13
Amsterdam 12
Boardman 12
Brasília 12
Brescia 12
Campinas 12
Dhaka 12
Lappeenranta 12
Memphis 12
Philadelphia 12
Belo Horizonte 11
Managua 11
Amman 10
Guayaquil 10
Porto Alegre 10
Quito 10
San José 10
Tashkent 10
Washington 10
Guatemala City 9
Kuala Lumpur 9
Las Vegas 9
Queens 9
Querétaro 9
San Salvador 9
Slough 9
Cairo 8
Chengdu 8
Esch-sur-Alzette 8
Falkenstein 8
Guangzhou 8
Haiphong 8
Hyderabad 8
Istanbul 8
Miami 8
Ninh Bình 8
Spokane 8
Totale 6.583
Salva come PNG Salva come JPEG
Nome #
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 335
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 291
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 191
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study 172
Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art 158
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 157
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 144
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 138
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 135
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis 133
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis 133
Ulcerative colitis : current pharmacotherapy and future directions 132
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 131
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 130
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 130
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 130
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 127
The role of filgotinib in ulcerative colitis and Crohn's disease 127
Inflammatory Bowel Disease and Colorectal Cancer 127
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 124
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 119
The Role of IL-23 Inhibitors in Crohn’s Disease 117
Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines 117
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 117
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 117
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 115
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 114
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 112
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis 110
Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era 108
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 108
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis 108
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 105
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease 104
Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis : effect of antiviral treatment 104
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 103
The Role of Fecal Microbiota Transplantation in IBD 102
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques 102
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 98
Small Bowel Cancer in Crohn’s Disease 98
P139 The learning curve of intestinal ultrasonography in assessing inflammatory bowel disease : preliminary results 98
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 97
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases 96
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 95
Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future 90
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? 90
Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study 90
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 90
Raising the bar in ulcerative colitis management 89
Gut and mesenteric lymph node involvement in pediatric patients infected with human immunodeficiency virus 85
Clostridioides difficile infection in hospital and community settings: summary document of a multidisciplinary group 85
Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question 84
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 84
The Management of Postoperative Recurrence in Crohn’s Disease 84
Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease 83
Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures 83
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience 82
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 82
Biosimilars of adalimumab: the upcoming challenge in IBD 79
Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that? 79
Bowel ultrasound is accurate in assessing disease activity in ulcerative colitis 78
Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows 77
Abdominal pain after minor trauma in a patient with Crohn's disease 77
JAK inhibitors in crohn’s disease: ready to go? 77
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 77
Risk factors for depression and anxiety in Crohn's disease 75
ASSESSMENT OF THE DISEASE EXTENSION IN CHILDREN AND ADOLESCENTS WITH IBD: COMPARISON OF BOWEL ULTRASOUND AND MAGNETIC RESONANCE ENTEROGRAPHY 74
Accuracy of a New Fujiifilm Blue Light Prototype in Predicting the Histology of Subcentimetric Polyps 74
Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of C-13-urea 74
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 74
An Unusual Case of Cardiac Involvement in Crohn's Disease 74
JAK inhibitors: Novel developments in management of ulcerative colitis 73
Psychological Functioning of Patients With Inflammatory Bowel Disease 73
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 73
Early Intestinal Ultrasound Predicts Long-Term Endoscopic Response to Biologics in Ulcerative Colitis 72
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease 72
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 71
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study 71
Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease 68
Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease 67
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 67
Can IL-23 be a good target for ulcerative colitis? 67
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 66
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 66
BOWEL ULTRASOUND IS ACCURATE IN ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS 66
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY 66
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients 66
Point-of-Care Ultrasound in Inflammatory Bowel Disease 66
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 65
Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation 65
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts 65
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease 64
Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn's disease 64
Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study 63
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 63
Patient's profiling for therapeutic management of inflammatory bowel disease: a tailored approach 63
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 62
The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease 61
Improving quality of care in endoscopy of inflammatory bowel disease: can we do better? 61
Modulation of sphingosine-1-phosphate in ulcerative colitis 61
Totale 9.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.849
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202292 0 0 0 73 1 5 0 1 0 2 5 5
2022/2023252 149 36 9 2 1 25 10 9 8 2 0 1
2023/202461 1 3 2 0 4 16 3 6 0 0 2 24
2024/20251.881 106 8 13 3 1 56 134 295 357 495 147 266
2025/20268.996 663 597 505 1.065 765 320 751 676 2.170 470 539 475
2026/20272.412 424 581 604 803 0 0 0 0 0 0 0 0
Totale 13.694